Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2...
Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s
healthcare company, today announced it will report second quarter
2020 financial results after the market close on Tuesday, August
11, 2020. Following the release, the Company will host a live
conference call and webcast at 4:30 p.m. ET to discuss the
Company’s financial results and provide a business update.
Investors interested in listening to the
conference call may do so by dialing (877) 407-2991 for domestic
callers or (201) 389-0925 for international callers. A live webcast
will be available in the Events and Presentations section of the
Investor Relations page at
https://ir.agiletherapeutics.com/events-and-presentations/, or by
Please log in approximately 10 minutes prior to
the scheduled start time. The archived webcast will be available in
the Events and Presentations section of the company's website.
About Agile Therapeutics,
Inc.Agile Therapeutics is a women's healthcare company
dedicated to fulfilling the unmet health needs of today’s women.
Our product candidates are designed to provide women with
contraceptive options that offer freedom from taking a daily pill,
without committing to a longer-acting method. Our initial product,
Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system
is a non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website at
www.agiletherapeutics.com. The Company may occasionally disseminate
material, nonpublic information on the Company’s website.
Follow Agile on LinkedIn and Twitter:
Source: Agile Therapeutics
Contact: Matt Riley Investor Relations